LYTTON LAURENCE W 13D and 13G filings for NeuroOne Medical Technologies Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-26 08:42 am Purchase |
2024-09-30 | 13G | NeuroOne Medical Technologies Corporation NMTC |
LYTTON LAURENCE W | 2,059,922 6.600% |
755,820 (+57.96%) |
Filing |
| 2024-01-11 1:04 pm Purchase |
2023-12-28 | 13G | NeuroOne Medical Technologies Corporation NMTC |
LYTTON LAURENCE W | 1,304,102 5.200% |
1,304,102 (New Position) |
Filing |